RBM34 Activators constitute a specialized category of chemical compounds designed to selectively enhance the activity of RNA-binding protein 34 (RBM34), also known as RNPC1. RBM34 is a multifunctional protein involved in various aspects of RNA metabolism, including pre-mRNA splicing, mRNA stability, and translation regulation. This RNA-binding protein plays a pivotal role in post-transcriptional gene regulation, contributing to the fine-tuning of gene expression in eukaryotic cells. The development of RBM34 Activators represents a significant scientific endeavor aimed at understanding and modulating the activity of this versatile RNA-binding protein, shedding light on its role in RNA biology. These activators are synthesized through intricate chemical engineering processes, with the goal of producing molecules that can specifically interact with RBM34, potentially modulating its RNA-binding affinity or revealing its natural regulatory mechanisms. Designing effective RBM34 Activators requires a deep understanding of the protein's structure, particularly its RNA-binding domains and potential binding motifs on RNA molecules.
The study of RBM34 Activators involves a multidisciplinary research approach, integrating techniques from molecular biology, biochemistry, and structural biology to elucidate how these compounds interact with RBM34. Scientists employ protein expression and purification methods to obtain RBM34 for further analysis. Functional assays, such as RNA binding assays and ribonucleoprotein complex formation assays, are used to assess the impact of activators on RBM34-mediated RNA interactions. Structural studies, including nuclear magnetic resonance (NMR) spectroscopy or X-ray crystallography, are instrumental in determining the three-dimensional structure of RBM34, identifying potential activator binding sites, and elucidating the conformational changes associated with activation. Computational modeling and molecular docking further aid in predicting the interactions between RBM34 and potential activators, guiding the rational design and optimization of these molecules for increased specificity and efficacy. Through this comprehensive research endeavor, the study of RBM34 Activators aims to advance our understanding of RNA biology, post-transcriptional gene regulation, and the intricate processes involved in shaping the RNA landscape within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may alter gene expression patterns through its impact on DNA methylation, potentially affecting RBM34. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is known to inhibit histone deacetylases, which can lead to changes in chromatin structure and gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and can influence gene transcription, potentially affecting genes like RBM34. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase and could indirectly impact gene expression, including that of RBM34. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which may lead to the transcriptional regulation of various genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to affect epigenetic marks and could hypothetically influence RBM34 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that could potentially increase RBM34 expression by altering chromatin accessibility. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences several cellular pathways and may affect the expression of genes involved in RNA processing. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO is used in biological research to modulate cellular pathways, possibly affecting gene expression profiles. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression and differentiation, potentially impacting the expression of genes like RBM34. | ||||||